Akorn Inc's Hi-Tech Pharmacal infringes Allergan glaucoma drug patents

NEW YORK (Reuters) - Acorn Inc's Hi-Tech Pharmacal Co, Inc infringed three Allergan Inc patents on its Lumigan topical glaucoma treatment, a U.S. appeals court ruled on Tuesday.